Markt geschlossen -
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
0.9329 USD | -3.82% |
|
-10.30% | +18.84% |
Kurzporträt
Mitarbeiterzahl: 18
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Alon Ben-Noon
FOU | Founder | 45 | 13.02.17 |
Or Eisenberg
DFI | Director of Finance/CFO | 43 | 01.06.21 |
Hagit Binder
COO | Chief Operating Officer | - | - |
Shiran Zimri
CTO | Chief Tech/Sci/R&D Officer | - | 01.02.20 |
Irit Shefer
CTO | Chief Tech/Sci/R&D Officer | - | 01.02.22 |
Ferenc Tracik
CTO | Chief Tech/Sci/R&D Officer | 60 | 01.12.21 |
Chief Tech/Sci/R&D Officer | 63 | - | |
Diana Shtossel
LAW | General Counsel | - | 01.01.22 |
Corporate Officer/Principal | - | 01.03.22 |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Director/Board Member | 56 | 21.12.21 | |
Chairman | 67 | 01.10.21 | |
Cary Claiborne
BRD | Director/Board Member | 64 | 01.12.21 |
Director/Board Member | 49 | 01.01.22 | |
Caren Deardorf
BRD | Director/Board Member | 59 | 21.12.21 |
Alon Ben-Noon
FOU | Founder | 45 | 13.02.17 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 18 037 006 | 13 085 886 ( 72,55 %) | 0 | 72,55 % |
Unternehmenskontakt
Neurosense Therapeutics Ltd.
11 HaMenofim Street Building B
46725, Herzliya
+
http://www.neurosense-tx.com![Straße NeuroSense Therapeutics Ltd.(NRSN)](https://cdn.zonebourse.com/static/address/130483704.png)
Sektor
![Analystenschätzungen](/images/consensus_flch.gif)
Verlauf des Gewinns je Aktie
% 1. Jan. | Kap. | |
---|---|---|
+18.84% | 16.83 Mio. | |
+16.42% | 122 Mrd. | |
+19.02% | 113 Mrd. | |
+3.14% | 22.66 Mrd. | |
-16.20% | 21.34 Mrd. | |
-39.57% | 16.92 Mrd. | |
-11.63% | 16.68 Mrd. | |
-16.15% | 16.61 Mrd. | |
+2.68% | 13.62 Mrd. | |
+21.16% | 11.04 Mrd. |
- Börse
- Aktien
- A3DFK1 Aktie
- Unternehmen NeuroSense Therapeutics Ltd.